Redox therapy for tumors

Details Redox therapy for tumors Redox therapy for tumors

2003-07-18

2010-12-28

Anderson, James D (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

N-c doai

C514S114000

Reexamination Certificate

active

07858659

ABSTRACT:
The invention provides methods and compositions for treatment of tumors comprising administering to subject bearing a tumor an effective amount of at least one agent that decreases the [GSH]2/[GSSG] ratio in the malignant cells of said tumor, wherein said at least one agent is administered continuously to said patient for a period of time within the range of from about 15 to about 75 hours.

REFERENCES:
patent: 6288110 (2001-09-01), Marikovsky
patent: 6589987 (2003-07-01), Kennedy
patent: 02056823 (2002-07-01), None
Huang et al. Mechanism and significance of increased glutathione level in human hepatocellular carcinoma and liver regeneration. The FASEB Journal, 2001, vol. 15, pp. 19-21; published online Nov. 9, 2000.
Ali-Osman et al. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA- DNA crosslinking and cytotoxcicity in human glioma cells. Mol. Pharm., 1996, vol. 49, pp. 1012-1020.
Nagendra et al. Effect of disulfiram administration on rat brain glutathione metabolism. Alcohol, 1994, vol. 11, pp. 7-10.
Gura et al. Systems for identifying new drugs are often faulty. Science, 1997, 278:1041-1042.
Johnson et al. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. British J. of Cancer, 2001, 84(10):1424-1431.
Bailey et al. J. Natl. Cancer Inst., 1997, vol. 89, No. 23, pp. 1789-1796.
Sharma et al. Clinical Cancer Research, Jul. 2001, vol. 7, pp. 1894-1900.
Johnson et al. Neurosurgery, 1987, vol. 20, No. 4, pp. 577-583 (Abstract attached).
R. Araya et al; “Hypoxia induces apoptosis in human neuroblastoma SK-N-MC cells by caspase activation accompanying cytochromecrelease from mitochondria”;FEBS Lett(1990); vol. 439; pp. 168-72; Federation of European Biochemical Societies.
J. R. Babson et al; “Inactivation of glutathione reductase by 2-chloroethyl nitrosourea-derived isocyanates”;Biochem. Biophys. Res. Commun. (1978); vol. 83; pp. 745-762; Academic Press.
D. Cen et al; “Disulfiram induces apoptosis in human melanoma cells: a redox-related process”;Molec Cancer Ther(2002); vol. 1; pp. 197-204.
M.B. Cohen et al; “Characterization of the inhibition of glutathione reductase and the recovery of enzyme activity in exponentially growing murine leukemia (L1210) cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea.”Biochem Pharm(1988); vol. 37; pp. 3317-3320; Pergamon Press PLC.
D.G. Cornwell et al; “Cytotoxicity of tocopherols and their quinones in drug-sensitive and multidrug-resistant leukemia cells”;Lipids(1998); vol. 33; pp. 295-301; AOCS Press.
J. Dai et al; “Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system”;Blood(1999); vol. 93; pp. 268-77; The American Society of Hematology.
D. L. Duval et al; “Regulation of hepatic nitric oxide synthase by reactive oxygen intermediates and glutathione”;Arch Biochem Biophys(1995); vol. 316; pp. 699-706; Academic Press Inc.
H. Esterbauer et al; “Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes”;Free Radic Biol Med(1991); vol. 11; pp. 81-128; Pergamon Press PLC.
T. M. Gottlieb et al; “p53 in growth control and neoplasia”;Biochim Biophys Acta(1996); vol. 1287; pp. 77-102; Elsevier Science B.V.
A. Hoffman et al; “Cessation of cell proliferation by adjustment of cell redox potential”;J Theoret Biol(2001); vol. 211; pp. 403-407; Academic Press.
D. E. Hutter et al; “Redox state changes in density-dependent regulation of proliferation”;Exp Cell Res(1997); vol. 232; pp. 435-438; Academic Press.
C. D. Kang et al; “Activation of c-jun N-terminal kinase/stress-activated protein kinase and the decreased ratio of Bcl-2 to Bax are associated with the auto-oxidized dopamine-induced apoptosis in PC12 cells”;Neurosci. Lett. (1998); vol. 256; pp. 37-40; Elsevier Science.
R. Kinscherf et al; “Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL: its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits”;FASEB J(1997); vol. 11; pp. 1317-1328.
M. Kito et al; “Arsenic Trioxide-Induced Apoptosis and its Enhancement by Buthionine Sulfoximine in Hepatocellular Carcinoma Cel Lines”;Biochemical and Biophysical Research Communications(2002); vol. 291; pp. 861-867; Elsevier Science.
T. Lahusen et al; “Alsterpaullone, a novel cyclin-dependent kinase inhibitor, induces apoptosis by activation of caspase-9 due to perturbation in mitochondrial membrane potential”;Molec Carcinogen(2003); vol. 36; pp. 183-194.
Y. J. Lee et al; “Glucose deprivation-induced cytotoxicity and alterations in mitogen-activated protein kinase activation are mediated by oxidative stress in multidrug-resistant human breast carcinoma cells”;J Biol Chem(1998); vol. 273; pp. 5294-5299; The American Society for Biochemistry and Molecular Biology, Inc.
C. J. Li et al; “Potent inhibition of tumor survival in vivo by beta-lapachone plus taxol: combining drugs imposes different artificial checkpoints”;Proc Natl Acad Sci USA. (1999); vol. 96; pp. 13369-13374.
Y. Li et al; “Selective killing of cancer cells by beta-lapachone: direct checkpoint activation as a strategy against cancer”;Proc Natl Acad Sci USA(2003); vol. 100; pp. 2674-2678.
G. Lizard et al; “Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production”;FASEB J. (1998); vol. 12; pp. 1651-1663.
S. Lord-Fontaine et al; “Enhancement of cytotoxicity of hydrogen peroxide by hyperthermia in chinese hamster ovary cells: role of antioxidant defenses”;Arch Biochem Biophys(1999); vol. 363; pp. 283-295; Academic Press.
A. Nicole et al; “Direct evidence for glutathione as mediator of apoptosis in neuronal cells”;Biomed Pharmacother(1998); vol. 52; pp. 349-355; Elsevier, Paris.
A. G. Paschka et al; “Induction of apoptosis in prostate cancer cell lines by the green tea component, (−)-epigallocatechin-3-gallate”;Cancer Lett(1998); vol. 130; pp. 1-7; Elsevier, Paris.
C. Ramachandran et al; “Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin”;Breast Cancer Res Treat(1999); vol. 54; pp. 269-278; Kluwer Academic Publishers.
M. M. Rimpler et al; “Protection against hydrogen peroxide cytotoxicity in rat-1 fibroblasts provided by the oncoprotein Bcl-2: maintenance of calcium homoeostasis is secondary to the effect of Bcl-2 on cellular glutathione”;Biochem J(1999); vol. 340(Pt 1); pp. 291-297; Bochemical Society.
L. Rossi et al; “Quinone toxicity in hepatocytes without oxidative stress”;Arch Biochem Biophys(1986); vol. 251; pp. 25-35.
P. K. Rudra et al; “Acrolein cytotoxicity and glutathione depletion in n-3 fatty acid sensitive- and resistant human tumor cells”;Anticancer Res(1999); vol. 19; pp. 461-469.
C.K. Sen et al; “Fas mediated apoptosis of human Jurkat T-cells: intracellular events and potentiation by redox-active alpha-lipoic acid”;Cell Death Differentiation(1999); vol. 6; pp. 481-491; Stockton Press.
R. Smaaland et al; “Glutathione content in human bone marrow and circadian stage relation to DNA synthesis”;J Natl Cancer Inst(1991); vol. 83; pp. 1092-1098.
A. C. Smith et al: “Pharmacokinetics of Buthionine Sulfoximine (NSC 326231) and Its Effect on Melphalan-induced Toxicity in Mice”;Cancer Research(1989); vol. 49; pp. 5385-5391.
S. Tamrakar et al; “Role of pRB dephosphorylation in cell cycle regulation”Frontiers in Bioscience(2000); vol. 5; pp. D121-D137.
D. E. Thornton et al; “Antioxidant and cytotoxic tocopheryl quinones in normal and cancer c

Affiliated with

Also associated with

Rating

Redox therapy for tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Redox therapy for tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Redox therapy for tumors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4222851